A Phase 1b, Open-label Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activities of IN10018 as Monotherapy and Combination Therapy in Subjects with Metastatic Melanoma

  • Shackleton, Mark (Primary Chief Investigator (PCI))
  • Hawkins, Cheryl-Ann (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date6/03/20 → 31/03/22

Keywords

  • Medical oncology
  • Metastatic Melanoma
  • Clinical trial